Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Biomerica Inc. BMRA

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.


Recent & Breaking News (NDAQ:BMRA)

Biomerica to present at the 18th Annual B. Riley & Co. investor conference on May 24, 2017

Marketwired May 23, 2017

Biomerica Announces Third Quarter Financial Results, Sales up 13.9% for Nine Months

Marketwired April 17, 2017

Biomerica to present at the 29th Annual ROTH conference on March 13, 2017

Marketwired March 9, 2017

15 Biggest Mid-Day Gainers For Monday

Benzinga.com  December 5, 2016

Biomerica to Present at the 9th Annual LD Micro Main Event

Accesswire November 30, 2016

Exclusive: Newly-Listed Biomerica's CEO Talks IBS, Tech And Patient Care

Benzinga.com  September 6, 2016

Biomerica Announces Third Quarter Financial Results, Sales up 10% for Nine Months

Marketwired April 15, 2016

All Board Members of Biomerica to Purchase Biomerica Common Stock Shares in the Open Market

Marketwired April 7, 2016

Biomerica Announced That Its International Patent Application for IBS Was Reviewed by the ISA and All Claims Have Been Deemed Novel and Non-Obvious

Marketwired March 14, 2016

Biomerica to Present at the ROTH Conference on March 16, 2016

Marketwired March 10, 2016

Biomerica Announces Second Quarter Financial Results

Marketwired January 15, 2016

Biomerica Announces Executive Advisor Appointment for Medical Affairs and Research

Marketwired January 8, 2016

OxySure (OXYS) Launches OxyTrac(TM) to Save Lives & Help Companies Stay Compliant

Accesswire December 10, 2015

Biomerica Reports First Quarter Results; Sales Up Over 24%

Marketwired October 16, 2015

Biomerica Working With FDA on Submission for Its IBS Product

Marketwired September 29, 2015

Biomerica Announces Year End Results

Marketwired September 1, 2015

Biomerica Announces Conference Call Regarding Its Product and Recent Developments in the Irritable Bowel Syndrome (IBS) Market

Marketwired July 6, 2015

Biomerica Announces Its First Brazilian ANVISA Approvals and a New Distribution Channel in Brazil

Marketwired June 29, 2015

Biomerica Announces Third Quarter Financial Results and Establishes Scientific Advisory Board

Marketwired April 15, 2015

Biomerica Announces Second Quarter Financial Results

Marketwired January 15, 2015